Proportion of individuals without treatment failure over the 48 study weeks by randomization arm in the (a) per protocol population and (b) intention to treat population.
Barbara Rossetti
Roberta Gagliardini
Genny Meini
Gaetana Sterrantino
Vincenzo Colangeli
Maria Carla Re
Alessandra Latini
Manuela Colafigli
Francesca Vignale
Stefano Rusconi
Valeria Micheli
Antonio Di Biagio
Giancarlo Orofino
Valeria Ghisetti
Alessandra Fantauzzi
Vincenzo Vullo
Pierfrancesco Grima
Daniela Francisci
Claudio Mastroianni
Andrea Antinori
Michele Trezzi
Lucia Lisi
Pierluigi Navarra
Benedetta Canovari
Antonella D’Arminio Monforte
Silvia Lamonica
Alessandro D’Avino
Maurizio Zazzi
Simona Di Giambenedetto
Andrea De Luca
10.1371/journal.pone.0187393.g002
https://plos.figshare.com/articles/figure/Proportion_of_individuals_without_treatment_failure_over_the_48_study_weeks_by_randomization_arm_in_the_a_per_protocol_population_and_b_intention_to_treat_population_/5621905
<p>Arm S = study arm (switch to maraviroc + darunavir/ritonavir); Arm C = continuation arm (continuation of previous 3-drug therapy).</p>
2017-11-21 18:28:05
randomized trial Objectives
3- drug ART
CCR 5-tropic virus
plasma drug levels
Femoral bone mineral density
RNA
virologically
maraviroc
week 48. Methods Patients
continuation arm
3- drug therapy
HIV
treatment failure
VF
48- week results
59 continuation arm
study arm
darunavir
QD